CGMP Alprostadil 

CGMP Alprostadil 
Product Description

Alprostadil is a vasodilator, and finds clinical use in treating erectile dysfunction, in improving blood flow in peripheral vascular disease, and in maintaining coronary circulation in neonates with vascular anomalies. The DMF for Alprostadil is on file with the US FDA, Canada, India, in many EU member states, and in several other countries.

Cayman Pharma s.r.o

  • CZ
  • 2015
    On CPHI since
Company types
Manufacturer/Innovator
Specifications
  • Details
    PGA1 max. 1.3% abs, PGB1 max. 0.1% abs, Total impurities max. 2.0% mol, Optical rotation [?]D20 = -60.0° to -70.0° (c=0.5, ethanol), etc.
  • Measured In
    g

Cayman Pharma s.r.o

  • CZ
  • 2015
    On CPHI since
Company types
Manufacturer/Innovator

More Products from Cayman Pharma s.r.o (4)

  • CGMP (+)-Cloprostenol (sodium salt) 

    Product CGMP (+)-Cloprostenol (sodium salt) 

    (+)-Cloprostenol is the active enantiomer of Cloprostenol. Cloprostenol is used in veterinary medicine as a luteolytic agent for the induction of estrus and the treatment of reproductive disorders in cattle, swine, and horses. The ASMF for (+)-Cloprostenol (sodium salt) is on file in several EU member states.
  • CGMP (±)-Cloprostenol (sodium salt) 

    Product CGMP (±)-Cloprostenol (sodium salt) 

    Cloprostenol is used in veterinary medicine as a luteolytic agent for the induction of estrus and the treatment of reproductive disorders in cattle, swine, and horses. The VMF for (±)-Cloprostenol (sodium salt) is on file with the US FDA, Canada, Russia, and the ASMF for (±)-Cloprostenol (sodium salt) is o...
  • CGMP Bimatoprost

    Product CGMP Bimatoprost

    Bimatoprost is a potent FP receptor agonist that finds clinical use as an ocular hypotensive agent for the treatment of glaucoma. The DMF is on file with the US FDA, Canada, and in several EU member states.
  • CGMP Epoprostenol (sodium salt)

    Product CGMP Epoprostenol (sodium salt)

    Epoprostenol is a potent vasodilator and antiplatelet substance with a very short physiologic half-life. It is used for the treatment of pulmonary hypertension. The DMF for Epoprostenol Sodium Salt is on file with the US FDA, Canada, Japan, Australia, and several EU member states.